Kane Biotech Dividends and Buybacks

Dividend criteria checks 0/6

Kane Biotech does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-2.6%

Buyback Yield

Total Shareholder Yield-2.6%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Here's Why Kane Biotech (CVE:KNE) Can Afford Some Debt

Nov 05
Here's Why Kane Biotech (CVE:KNE) Can Afford Some Debt

Is Kane Biotech (CVE:KNE) A Risky Investment?

Jul 14
Is Kane Biotech (CVE:KNE) A Risky Investment?

Is Kane Biotech (CVE:KNE) A Risky Investment?

Mar 27
Is Kane Biotech (CVE:KNE) A Risky Investment?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if KNE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if KNE's dividend payments have been increasing.


Dividend Yield vs Market

Kane Biotech Dividend Yield vs Market
How does KNE dividend yield compare to the market?
SegmentDividend Yield
Company (KNE)n/a
Market Bottom 25% (CA)1.8%
Market Top 25% (CA)6.2%
Industry Average (Biotechs)2.3%
Analyst forecast (KNE) (up to 3 years)n/a

Notable Dividend: Unable to evaluate KNE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate KNE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate KNE's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as KNE has not reported any payouts.


Discover strong dividend paying companies